Jane Street’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History

Jane Street’s Portfolio CYAD Stock Details CYAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-11,122	Closed	-$44K	–	11331
2021 Q4	$44K	Buy	+11,122	New	+$46.7K	﹤0.01%	9582
2020 Q1	–	Sell	-10,790	Closed	-$117K	–	6189
2019 Q4	$117K	Buy	+10,790	New	+$109K	﹤0.01%	4832
2018 Q2	–	Sell	-16,816	Closed	-$586K	–	5792
2018 Q1	$586K	Buy	16,816 +10,562	+169%	+$439K	﹤0.01%	3305
2017 Q4	$260K	Buy	+6,254	New	+$313K	﹤0.01%	3914

Other funds holding CYAD

FIG

Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Jane Street's CYAD Position: Q1 2022 in Review

Jane Street sold out of Celyad Oncology SA American Depositary Shares (CYAD) in Q1 2022, closing a stake of 11,122 shares — an estimated $44K sold.

Jane Street first reported a position in CYAD in Q4 2017 and held it in 4 quarters. The position peaked at $586K in Q1 2018. 8 funds tracked by Wall St. Rank hold CYAD as of Q1 2022.

Jane Street reported no remaining Celyad Oncology SA American Depositary Shares position as of Q1 2022 after selling out during the quarter.
Jane Street sold 11,122 Celyad Oncology SA American Depositary Shares shares in Q1 2022, an estimated $44K.
Jane Street first reported a position in Celyad Oncology SA American Depositary Shares in Q4 2017 and held it in 4 quarters.
Jane Street's Celyad Oncology SA American Depositary Shares position peaked at $586K in Q1 2018.
8 funds tracked by Wall St. Rank held Celyad Oncology SA American Depositary Shares as of Q1 2022.

Based on Jane Street's 13F filing for Q1 2022, filed 17 May 2022.